Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 660

1.

Blood Vessel Invasion Is a Strong Predictor of Postoperative Recurrence in Endometrial Cancer.

Sato M, Taguchi A, Fukui Y, Kawata A, Taguchi S, Kashiyama T, Eguchi S, Inoue T, Tomio K, Tanikawa M, Sone K, Mori M, Nagasaka K, Adachi K, Ikemura M, Domoto Y, Arimoto T, Oda K, Fukayama M, Osuga Y, Fujii T.

Int J Gynecol Cancer. 2018 Apr 16. doi: 10.1097/IGC.0000000000001262. [Epub ahead of print]

PMID:
29664845
2.

Histological transformation of MALT lymphoma to plasma cell leukemia after rituximab-containing therapy.

Suzuki Y, Honda A, Nakazaki K, Mizuno H, Ikemura M, Shinozaki-Ushiku A, Nakamura F, Fukayama M, Kurokawa M.

Ann Hematol. 2018 Mar 26. doi: 10.1007/s00277-018-3300-2. [Epub ahead of print] No abstract available.

PMID:
29582109
3.

Sessile serrated adenoma detection rate is correlated with adenoma detection rate.

Ohki D, Tsuji Y, Shinozaki T, Sakaguchi Y, Minatsuki C, Kinoshita H, Niimi K, Ono S, Hayakawa Y, Yoshida S, Yamada A, Kodashima S, Yamamichi N, Hirata Y, Ushiku T, Fujishiro M, Fukayama M, Koike K.

World J Gastrointest Oncol. 2018 Mar 15;10(3):82-90. doi: 10.4251/wjgo.v10.i3.82.

4.

CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8+/Foxp3+ T cells.

Abe H, Saito R, Ichimura T, Iwasaki A, Yamazawa S, Shinozaki-Ushiku A, Morikawa T, Ushiku T, Yamashita H, Seto Y, Fukayama M.

Virchows Arch. 2018 Mar 13. doi: 10.1007/s00428-018-2332-2. [Epub ahead of print]

PMID:
29536167
5.

Eculizumab treatment for ischemic enteritis accompanied with paroxysmal nocturnal hemoglobinuria: a case report and literature review.

Yasunaga M, Taoka K, Nakagawa H, Yamada A, Abe H, Jona M, Nishikawa M, Nakazaki K, Yatomi Y, Fukayama M, Koike K, Kurokawa M.

Ann Hematol. 2018 Mar 13. doi: 10.1007/s00277-018-3286-9. [Epub ahead of print] No abstract available.

PMID:
29532162
6.

Extraskeletal Osteosarcoma: MDM2 and H3K27me3 analysis of 19 cases suggest disease heterogeneity.

Makise N, Sekimizu M, Kubo T, Wakai S, Watanabe SI, Kato T, Kinoshita T, Hiraoka N, Fukayama M, Kawai A, Ichikawa H, Yoshida A.

Histopathology. 2018 Feb 28. doi: 10.1111/his.13506. [Epub ahead of print]

PMID:
29489027
7.

Synergistic Cytotoxic Effect on Gastric Cancer Cells of an Immunotoxin Cocktail in Which Antibodies Recognize Different Epitopes on CDH17.

Kusano-Arai O, Iwanari H, Kudo S, Kikuchi C, Yui A, Akiba H, Matsusaka K, Kaneda A, Fukayama M, Tsumoto K, Hamakubo T.

Monoclon Antib Immunodiagn Immunother. 2018 Feb;37(1):1-11. doi: 10.1089/mab.2017.0043.

PMID:
29474162
8.

A 19-Gauge Histology Needle Versus a 19-Gauge Standard Needle in Endoscopic Ultrasound-Guided Fine-Needle Aspiration for Solid Lesions: A Multicenter Randomized Comparison Study (GREATER Study).

Iwashita T, Nakai Y, Mukai T, Togawa O, Matsubara S, Hatano Y, Hara A, Tanaka M, Shibahara J, Fukayama M, Isayama H, Yasuda I.

Dig Dis Sci. 2018 Apr;63(4):1043-1051. doi: 10.1007/s10620-018-4913-y. Epub 2018 Feb 21.

PMID:
29464585
9.

Inflammatory Cytokines Induce Podoplanin Expression at the Tumor Invasive Front.

Kunita A, Baeriswyl V, Meda C, Cabuy E, Takeshita K, Giraudo E, Wicki A, Fukayama M, Christofori G.

Am J Pathol. 2018 Feb 17. pii: S0002-9440(17)30793-9. doi: 10.1016/j.ajpath.2018.01.016. [Epub ahead of print]

PMID:
29458011
10.

Distinct Chemopreventive Effects of Aspirin in Diffuse and Intestinal-Type Gastric Cancer.

Niikura R, Hayakawa Y, Hirata Y, Konishi M, Suzuki N, Ihara S, Yamada A, Ushiku T, Fujishiro M, Fukayama M, Koike K.

Cancer Prev Res (Phila). 2018 Feb 16. doi: 10.1158/1940-6207.CAPR-17-0276. [Epub ahead of print]

PMID:
29453233
11.

CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity.

Fujiwara N, Nakagawa H, Enooku K, Kudo Y, Hayata Y, Nakatsuka T, Tanaka Y, Tateishi R, Hikiba Y, Misumi K, Tanaka M, Hayashi A, Shibahara J, Fukayama M, Arita J, Hasegawa K, Hirschfield H, Hoshida Y, Hirata Y, Otsuka M, Tateishi K, Koike K.

Gut. 2018 Feb 6. pii: gutjnl-2017-315193. doi: 10.1136/gutjnl-2017-315193. [Epub ahead of print]

PMID:
29437870
12.

The Japanese Society of Pathology Guidelines on the handling of pathological tissue samples for genomic research: Standard operating procedures based on empirical analyses.

Kanai Y, Nishihara H, Miyagi Y, Tsuruyama T, Taguchi K, Katoh H, Takeuchi T, Gotoh M, Kuramoto J, Arai E, Ojima H, Shibuya A, Yoshida T, Akahane T, Kasajima R, Morita KI, Inazawa J, Sasaki T, Fukayama M, Oda Y.

Pathol Int. 2018 Feb;68(2):63-90. doi: 10.1111/pin.12631.

PMID:
29431262
13.

Protrusion on the Depressed Surface of Non-polypoid T1 Colorectal Cancer Is Associated with Venous Invasion.

Shinagawa T, Hata K, Morikawa T, Takiyama H, Otani K, Nishikawa T, Tanaka T, Kiyomatsu T, Kawai K, Nozawa H, Ishihara S, Nakamura H, Fukayama M, Watanabe T.

Anticancer Res. 2018 Feb;38(2):993-1002.

PMID:
29374732
14.

Value of FDG-PET/CT Volumetry After Chemoradiotherapy in Rectal Cancer.

Okuno T, Kawai K, Koyama K, Takahashi M, Ishihara S, Momose T, Morikawa T, Fukayama M, Watanabe T.

Dis Colon Rectum. 2018 Mar;61(3):320-327. doi: 10.1097/DCR.0000000000000959.

PMID:
29360680
15.

Transparency-enhancing technology allows three-dimensional assessment of gastrointestinal mucosa: A porcine model.

Mizutani H, Ono S, Ushiku T, Kudo Y, Ikemura M, Kageyama N, Yamamichi N, Fujishiro M, Someya T, Fukayama M, Koike K, Onodera H.

Pathol Int. 2018 Feb;68(2):102-108. doi: 10.1111/pin.12627. Epub 2018 Jan 17.

PMID:
29341375
16.

Clarifying the Distinction Between Malignant Peripheral Nerve Sheath Tumor and Dedifferentiated Liposarcoma: A Critical Reappraisal of the Diagnostic Utility of MDM2 and H3K27me3 Status.

Makise N, Sekimizu M, Kubo T, Wakai S, Hiraoka N, Komiyama M, Fukayama M, Kawai A, Ichikawa H, Yoshida A.

Am J Surg Pathol. 2018 May;42(5):656-664. doi: 10.1097/PAS.0000000000001014.

PMID:
29309298
17.

Nine primary malignant neoplasms-involving the esophagus, stomach, colon, rectum, prostate, and external ear canal-without microsatellite instability: a case report.

Arakawa K, Hata K, Yamamoto Y, Nishikawa T, Tanaka T, Kiyomatsu T, Kawai K, Nozawa H, Yoshida M, Fukuhara H, Fujishiro M, Morikawa T, Yamasoba T, Koike K, Fukayama M, Watanabe T.

BMC Cancer. 2018 Jan 4;18(1):24. doi: 10.1186/s12885-017-3973-2.

18.

Gastric pyloric gland adenoma: a multicentre clinicopathological study of 67 cases.

Choi WT, Brown I, Ushiku T, Yozu M, Setia N, Srivastava A, Johncilla M, Pai RK, Gill RM, Fukayama M, Misdraji J, Lauwers GY.

Histopathology. 2018 May;72(6):1007-1014. doi: 10.1111/his.13460. Epub 2018 Mar 5.

PMID:
29278427
19.

EVI1 modulates oncogenic role of GPC1 in pancreatic carcinogenesis.

Tanaka M, Ishikawa S, Ushiku T, Morikawa T, Isagawa T, Yamagishi M, Yamamoto H, Katoh H, Takeshita K, Arita J, Sakamoto Y, Hasegawa K, Kokudo N, Fukayama M.

Oncotarget. 2017 Sep 1;8(59):99552-99566. doi: 10.18632/oncotarget.20601. eCollection 2017 Nov 21.

20.

Clinical features and outcomes of secondary intraocular lymphoma.

Karakawa A, Taoka K, Kaburaki T, Tanaka R, Shinozaki-Ushiku A, Hayashi H, Miyagi-Maeshima A, Nishimura Y, Uekusa T, Kojima Y, Fukayama M, Kurokawa M, Aihara M.

Br J Haematol. 2017 Nov 16. doi: 10.1111/bjh.15005. [Epub ahead of print] No abstract available.

PMID:
29143310
21.

Lipocalin-type prostaglandin D synthase-derived PGD2 attenuates malignant properties of tumor endothelial cells.

Omori K, Morikawa T, Kunita A, Nakamura T, Aritake K, Urade Y, Fukayama M, Murata T.

J Pathol. 2018 Jan;244(1):84-96. doi: 10.1002/path.4993. Epub 2017 Nov 10.

PMID:
29124765
22.

Digital quantitative analysis of mast cell infiltration in interstitial cystitis.

Akiyama Y, Maeda D, Morikawa T, Niimi A, Nomiya A, Yamada Y, Igawa Y, Goto A, Fukayama M, Homma Y.

Neurourol Urodyn. 2018 Feb;37(2):650-657. doi: 10.1002/nau.23365. Epub 2017 Oct 24.

PMID:
29065222
23.

Polymorphic lymphoproliferative disorders in patients with rheumatoid arthritis are associated with a better clinical outcome.

Tsukui D, Kanda H, Shinozaki-Ushiku A, Tateishi S, Takeshima Y, Nagafuchi Y, Sasaki O, Iwasaki Y, Harada H, Shibuya M, Sumitomo S, Shoda H, Kubo K, Fujio K, Nakamura F, Kurokawa M, Fukayama M, Yamamoto K.

Mod Rheumatol. 2017 Oct 23:1-5. doi: 10.1080/14397595.2017.1387223. [Epub ahead of print]

PMID:
29057700
24.

Loss of Stromal Antigen 2 (STAG2) Expression in Upper Urinary Tract Carcinoma: Differential Prognostic Effect According to the Ki-67 Proliferating Index.

Miyakawa J, Morikawa T, Miyama Y, Nakagawa T, Kawai T, Homma Y, Fukayama M.

Ann Surg Oncol. 2017 Dec;24(13):4059-4066. doi: 10.1245/s10434-017-6097-7. Epub 2017 Oct 2.

PMID:
28967037
25.

Histone modification alteration coordinated with acquisition of promoter DNA methylation during Epstein-Barr virus infection.

Funata S, Matsusaka K, Yamanaka R, Yamamoto S, Okabe A, Fukuyo M, Aburatani H, Fukayama M, Kaneda A.

Oncotarget. 2017 Jul 21;8(33):55265-55279. doi: 10.18632/oncotarget.19423. eCollection 2017 Aug 15.

26.

Giant gastrointestinal stromal tumor of the vermiform appendix: A case report.

Kaneko M, Kawai K, Murono K, Nishikawa T, Sasaki K, Otani K, Yasuda K, Tanaka T, Kiyomatsu T, Hata K, Nozawa H, Ishihara S, Hayashi A, Shinozaki-Ushiku A, Fukayama M, Watanabe T.

Mol Clin Oncol. 2017 Sep;7(3):399-403. doi: 10.3892/mco.2017.1334. Epub 2017 Jul 19.

27.

Interleukin-6-dependent growth in a newly established plasmablastic lymphoma cell line and its therapeutic targets.

Mine S, Hishima T, Suganuma A, Fukumoto H, Sato Y, Kataoka M, Sekizuka T, Kuroda M, Suzuki T, Hasegawa H, Fukayama M, Katano H.

Sci Rep. 2017 Aug 31;7(1):10188. doi: 10.1038/s41598-017-10684-5.

28.

A case of delayed exacerbation of interstitial lung disease after discontinuation of temsirolimus.

Matsuki R, Okuda K, Mitani A, Yamauchi Y, Tanaka G, Kume H, Homma Y, Hinata M, Hayashi A, Shibahara J, Fukayama M, Nagase T.

Respir Med Case Rep. 2017 Aug 11;22:158-163. doi: 10.1016/j.rmcr.2017.08.008. eCollection 2017.

29.

Results of a 36-year surveillance program for ulcerative colitis-associated neoplasia in the Japanese population.

Kishikawa J, Hata K, Kazama S, Anzai H, Shinagawa T, Murono K, Kaneko M, Sasaki K, Yasuda K, Otani K, Nishikawa T, Tanaka T, Kiyomatsu T, Kawai K, Nozawa H, Ishihara S, Morikawa T, Fukayama M, Watanabe T.

Dig Endosc. 2018 Mar;30(2):236-244. doi: 10.1111/den.12955. Epub 2017 Nov 2.

PMID:
28836702
30.

Regulation of tumour related genes by dynamic epigenetic alteration at enhancer regions in gastric epithelial cells infected by Epstein-Barr virus.

Okabe A, Funata S, Matsusaka K, Namba H, Fukuyo M, Rahmutulla B, Oshima M, Iwama A, Fukayama M, Kaneda A.

Sci Rep. 2017 Aug 11;7(1):7924. doi: 10.1038/s41598-017-08370-7.

31.

Detection of residual metastatic tumor in the brain following Gamma Knife radiosurgery using a single or a series of magnetic resonance imaging scans: An autopsy study.

Sakuramachi M, Igaki H, Ikemura M, Yamashita H, Okuma K, Sekiya N, Hayakawa Y, Sakumi A, Takahashi W, Hasegawa H, Fukayama M, Nakagawa K.

Oncol Lett. 2017 Aug;14(2):2033-2040. doi: 10.3892/ol.2017.6359. Epub 2017 Jun 9.

32.

Establishment of highly metastatic KRAS mutant lung cancer cell sublines in long-term three-dimensional low attachment cultures.

Nakano T, Kanai Y, Amano Y, Yoshimoto T, Matsubara D, Shibano T, Tamura T, Oguni S, Katashiba S, Ito T, Murakami Y, Fukayama M, Murakami T, Endo S, Niki T.

PLoS One. 2017 Aug 7;12(8):e0181342. doi: 10.1371/journal.pone.0181342. eCollection 2017.

33.

Immunogenetic Profiling for Gastric Cancers Identifies Sulfated Glycosaminoglycans as Major and Functional B Cell Antigens in Human Malignancies.

Katoh H, Komura D, Konishi H, Suzuki R, Yamamoto A, Kakiuchi M, Sato R, Ushiku T, Yamamoto S, Tatsuno K, Oshima T, Nomura S, Seto Y, Fukayama M, Aburatani H, Ishikawa S.

Cell Rep. 2017 Aug 1;20(5):1073-1087. doi: 10.1016/j.celrep.2017.07.016.

34.

Integration of Recurrent Somatic Mutations with Clinical Outcomes: A Pooled Analysis of 1049 Patients with Clear Cell Renal Cell Carcinoma.

Manley BJ, Zabor EC, Casuscelli J, Tennenbaum DM, Redzematovic A, Becerra MF, Benfante N, Sato Y, Morikawa T, Kume H, Fukayama M, Homma Y, Ogawa S, Arcila ME, Voss MH, Feldman DR, Coleman JA, Reuter VE, Motzer RJ, Russo P, Hsieh JJ, Hakimi AA.

Eur Urol Focus. 2017 Oct;3(4-5):421-427. doi: 10.1016/j.euf.2016.06.015. Epub 2016 Jul 16.

PMID:
28753773
35.

The pseudo-SAH sign: an imaging pitfall in postmortem computed tomography.

Shirota G, Gonoi W, Ikemura M, Ishida M, Shintani Y, Abe H, Fukayama M, Higashida T, Okuma H, Abe O.

Int J Legal Med. 2017 Nov;131(6):1647-1653. doi: 10.1007/s00414-017-1651-1. Epub 2017 Jul 20.

PMID:
28730501
36.

Dedifferentiated Liposarcoma With Epithelioid/Epithelial Features.

Makise N, Yoshida A, Komiyama M, Nakatani F, Yonemori K, Kawai A, Fukayama M, Hiraoka N.

Am J Surg Pathol. 2017 Nov;41(11):1523-1531. doi: 10.1097/PAS.0000000000000910.

PMID:
28719466
37.

Inactivating mutations and hypermethylation of the NKX2-1/TTF-1 gene in non-terminal respiratory unit-type lung adenocarcinomas.

Matsubara D, Soda M, Yoshimoto T, Amano Y, Sakuma Y, Yamato A, Ueno T, Kojima S, Shibano T, Hosono Y, Kawazu M, Yamashita Y, Endo S, Hagiwara K, Fukayama M, Takahashi T, Mano H, Niki T.

Cancer Sci. 2017 Sep;108(9):1888-1896. doi: 10.1111/cas.13313. Epub 2017 Jul 29.

38.

Antipodocalyxin Antibody chPcMab-47 Exerts Antitumor Activity in Mouse Xenograft Models of Colorectal Adenocarcinomas.

Kaneko MK, Kunita A, Yamada S, Nakamura T, Yanaka M, Saidoh N, Chang YW, Handa S, Ogasawara S, Ohishi T, Abe S, Itai S, Harada H, Kawada M, Nishioka Y, Fukayama M, Kato Y.

Monoclon Antib Immunodiagn Immunother. 2017 Aug;36(4):157-162. doi: 10.1089/mab.2017.0020. Epub 2017 Jun 30.

PMID:
28665782
39.

Safety and efficacy of venous reconstruction in liver resection using cryopreserved homologous veins.

Yamamoto M, Akamatsu N, Hayashi A, Togashi J, Sakamoto Y, Tamura S, Hasegawa K, Fukayama M, Makuuchi M, Kokudo N.

J Hepatobiliary Pancreat Sci. 2017 Sep;24(9):511-519. doi: 10.1002/jhbp.488. Epub 2017 Aug 4.

PMID:
28660678
40.

Integrative analysis of genomic alterations in triple-negative breast cancer in association with homologous recombination deficiency.

Kawazu M, Kojima S, Ueno T, Totoki Y, Nakamura H, Kunita A, Qu W, Yoshimura J, Soda M, Yasuda T, Hama N, Saito-Adachi M, Sato K, Kohsaka S, Sai E, Ikemura M, Yamamoto S, Ogawa T, Fukayama M, Tada K, Seto Y, Morishita S, Hazama S, Shibata T, Yamashita Y, Mano H.

PLoS Genet. 2017 Jun 21;13(6):e1006853. doi: 10.1371/journal.pgen.1006853. eCollection 2017 Jun.

41.

Quantitative computed tomography texture analysis for estimating histological subtypes of thymic epithelial tumors.

Yasaka K, Akai H, Nojima M, Shinozaki-Ushiku A, Fukayama M, Nakajima J, Ohtomo K, Kiryu S.

Eur J Radiol. 2017 Jul;92:84-92. doi: 10.1016/j.ejrad.2017.04.017. Epub 2017 Apr 25.

PMID:
28624025
42.

Intraoperative imaging of hepatic cancers using γ-glutamyltranspeptidase-specific fluorophore enabling real-time identification and estimation of recurrence.

Miyata Y, Ishizawa T, Kamiya M, Yamashita S, Hasegawa K, Ushiku A, Shibahara J, Fukayama M, Urano Y, Kokudo N.

Sci Rep. 2017 Jun 14;7(1):3542. doi: 10.1038/s41598-017-03760-3.

43.

Diagnostic utility of Ki-67 immunohistochemistry in small endoscopic biopsies of the ureter and renal pelvis.

Koyama Y, Morikawa T, Miyakawa J, Miyama Y, Nakagawa T, Homma Y, Fukayama M.

Pathol Res Pract. 2017 Jul;213(7):737-741. doi: 10.1016/j.prp.2017.04.009. Epub 2017 Apr 20.

PMID:
28554752
44.

Lymphogenous metastasis to the transverse colon that originated from signet-ring cell gastric cancer: A case report and review of the literature.

Sonoda H, Kawai K, Yamaguchi H, Murono K, Kaneko M, Nishikawa T, Otani K, Sasaki K, Yasuda K, Tanaka T, Kiyomatsu T, Hata K, Nozawa H, Ishihara S, Aikou S, Yamashita H, Ushiku T, Seto Y, Fukayama M, Watanabe T.

Clin Res Hepatol Gastroenterol. 2017 Dec;41(6):e81-e86. doi: 10.1016/j.clinre.2017.04.002. Epub 2017 May 16.

PMID:
28526245
45.

Gastric Cancer With Primitive Enterocyte Phenotype: An Aggressive Subgroup of Intestinal-type Adenocarcinoma.

Yamazawa S, Ushiku T, Shinozaki-Ushiku A, Hayashi A, Iwasaki A, Abe H, Tagashira A, Yamashita H, Seto Y, Aburatani H, Fukayama M.

Am J Surg Pathol. 2017 Jul;41(7):989-997. doi: 10.1097/PAS.0000000000000869.

PMID:
28505005
46.

Mint3-mediated L1CAM expression in fibroblasts promotes cancer cell proliferation via integrin α5β1 and tumour growth.

Nakaoka HJ, Tanei Z, Hara T, Weng JS, Kanamori A, Hayashi T, Sato H, Orimo A, Otsuji K, Tada K, Morikawa T, Sasaki T, Fukayama M, Seiki M, Murakami Y, Sakamoto T.

Oncogenesis. 2017 May 15;6(5):e334. doi: 10.1038/oncsis.2017.27.

47.

ChLpMab-23: Cancer-Specific Human-Mouse Chimeric Anti-Podoplanin Antibody Exhibits Antitumor Activity via Antibody-Dependent Cellular Cytotoxicity.

Kaneko MK, Nakamura T, Kunita A, Fukayama M, Abe S, Nishioka Y, Yamada S, Yanaka M, Saidoh N, Yoshida K, Fujii Y, Ogasawara S, Kato Y.

Monoclon Antib Immunodiagn Immunother. 2017 Jun;36(3):104-112. doi: 10.1089/mab.2017.0014. Epub 2017 May 15.

PMID:
28504613
48.

Oncogenic histone methyltransferase EZH2: A novel prognostic marker with therapeutic potential in endometrial cancer.

Oki S, Sone K, Oda K, Hamamoto R, Ikemura M, Maeda D, Takeuchi M, Tanikawa M, Mori-Uchino M, Nagasaka K, Miyasaka A, Kashiyama T, Ikeda Y, Arimoto T, Kuramoto H, Wada-Hiraike O, Kawana K, Fukayama M, Osuga Y, Fujii T.

Oncotarget. 2017 Jun 20;8(25):40402-40411. doi: 10.18632/oncotarget.16316.

49.

Epstein-Barr virus infection induces genome-wide de novo DNA methylation in non-neoplastic gastric epithelial cells.

Matsusaka K, Funata S, Fukuyo M, Seto Y, Aburatani H, Fukayama M, Kaneda A.

J Pathol. 2017 Aug;242(4):391-399. doi: 10.1002/path.4909. Epub 2017 May 25.

PMID:
28418084
50.

Laminar crystal deposition in large vessels in a patient with crystalglobulinemia.

Shintani-Domoto Y, Shinozaki-Ushiku A, Okuma H, Kurokawa M, Fukayama M.

Pathol Int. 2017 May;67(5):269-272. doi: 10.1111/pin.12526. Epub 2017 Mar 31.

PMID:
28371144

Supplemental Content

Loading ...
Support Center